1887

Abstract

The activity of amphotericin B (AMB) alone and in combination with rifampicin (RIF) and doxycycline (DOX) was tested against the biofilms of 30 clinical isolates of non- (NAC) species namely, , and . The killing activity of AMB at 10×MIC was significantly increased in combination with either antibiotic. With RIF, the killing activity increased by 20.6, 23.5 and 14 % against the biofilms of , and , respectively; with DOX, the killing activity increased by 30.64, 35.28 and 31.13 %, respectively. Pre-exposure of the isolates to the same combinations significantly reduced the number of colonized cells in the biofilms by 20, 25.14 and 13.07 % with RIF for , and , respectively, and by 18.94, 24.52 and 29.15 % with DOX, respectively. The data showed that combination of RIF or DOX with AMB enhanced the killing activity of the antifungal agent against biofilms of NAC species. Whether such an effect operates against biofilm-associated infections needs to be clarified by further studies.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.46952-0
2007-05-01
2019-10-21
Loading full text...

Full text loading...

/deliver/fulltext/jmm/56/5/645.html?itemId=/content/journal/jmm/10.1099/jmm.0.46952-0&mimeType=html&fmt=ahah

References

  1. Arroyo, J., Medoff, G. & Kobayashi, G. S. ( 1977; ). Therapy of murine aspergillosis with amphotericin B in combination with rifampin or 5-fluorocytosine. Antimicrob Agents Chemother 11, 21–25.[CrossRef]
    [Google Scholar]
  2. Baillie, G. S. & Douglas, L. G. ( 1998; ). Effect of growth rate on resistance of Candida albicans biofilms to antifungal agents. Antimicrob Agents Chemother 42, 1900–1905.
    [Google Scholar]
  3. Battaner, E. & Vasquez, D. ( 1971; ). Inhibitors of protein synthesis by ribosomes of the 8-S type. Biochim Biophys Acta 254, 316–330.[CrossRef]
    [Google Scholar]
  4. Chandra, J., Mukherjee, P. K., Leidich, S. D., Faddoul, F. F., Hoyer, L. L., Douglas, L. J. & Ghannoum, M. A. ( 2001; ). Antifungal resistance of candidal biofilms formed on denture acrylic in vitro. J Dent Res 80, 903–908.[CrossRef]
    [Google Scholar]
  5. Christenson, J. C., Itamar Shalit, T., David, T., Welch, F., Guruswamy, A. & Marks, M. I. ( 1987; ). Synergistic action of amphotericin B and rifampin against Rhizopus species. Antimicrob Agents Chemother 31, 1775–1778.[CrossRef]
    [Google Scholar]
  6. Clinical and Laboratory Standards Institute ( 2002; ). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; approved standard, 2nd edn, document M27–2A. Wayne, PA: Clinical and Laboratory Standards Institute.
  7. Costerton, J. W., Stewart, P. & Greenberg, E. ( 1999; ). Bacterial biofilms: a common cause of persistent infections. Science 284, 1318–1322.[CrossRef]
    [Google Scholar]
  8. Dorocka-Bobkowska, B., Konopka, K. & Düzgünes, N. ( 2003; ). Influence of antifungal polyenes on the adhesion of Candida albicans and Candida glabrata to human epithelial cells in vitro. Arch Oral Biol 48, 805–814.[CrossRef]
    [Google Scholar]
  9. Douglas, L. J. ( 2003; ). Candida biofilms and their role in infection. Trends Microbiol 11, 30–36.[CrossRef]
    [Google Scholar]
  10. Edwards, J. E., Jr, Morrison, J., Henderson, D. K. & Montgomerie, J. Z. ( 1980; ). Combined effect of amphotericin B and rifampin on Candida species. Antimicrob Agents Chemother 17, 484–487.[CrossRef]
    [Google Scholar]
  11. El-Azizi, M. A., Starks, S. & Khardori, N. ( 2004; ). Interactions of Candida albicans and other Candida spp. and bacteria in the biofilms. J Appl Microbiol 96, 1067–1073.[CrossRef]
    [Google Scholar]
  12. El-Azizi, M., Rao, S., Kanchanapoom, T. & Khardori, N. ( 2005; ). In vitro activity of vancomycin, quinupristin/dalfopristin, and linezolid against intact and disrupted biofilms of staphylococci. Ann Clin Microbiol Antimicrob 4, 2 [CrossRef]
    [Google Scholar]
  13. Ellepola, A. N.. & Samaranayake, L. P. ( 1998; ). Adhesion of oral Candida albicans isolates to denture acrylic following limited exposure to antifungal agents. Arch Oral Biol 43, 999–1007.[CrossRef]
    [Google Scholar]
  14. Hughes, C. E., Harris, L. C., Peterson, L. R. & Gerding, D. N. ( 1984; ). Enhancement of the in vitro activity of amphotericin B against Aspergillus spp. by tetracycline analogs. Antimicrob Agents Chemother 26, 837–840.[CrossRef]
    [Google Scholar]
  15. Huppert, M., Sun, S. H. & Vukovich, K. R. ( 1974; ). Combined amphotericin B-tetracycline therapy for experimental coccidioidomycosis. Antimicrob Agents Chemother 5, 473–478.[CrossRef]
    [Google Scholar]
  16. Kinsky, S. C. ( 1970; ). Antibiotic interactions with model membranes. Annu Rev Pharmacol 10, 119–142.[CrossRef]
    [Google Scholar]
  17. Krcmery, V. & Barnes, A. J. ( 2002; ). Non-albicans Candida sp. causing fungaemia: pathogenicity and antifungal resistance. J Hosp Infect 50, 243–260.[CrossRef]
    [Google Scholar]
  18. Kuhn, D. M., Chandra, J., Mukherjee, P. K. & Ghannoum, M. A. ( 2002; ). Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infect Immun 70, 878–888.[CrossRef]
    [Google Scholar]
  19. Kumamoto, C. A. ( 2002; ). Candida biofilms. Curr Opin Microbiol 5, 608–611.[CrossRef]
    [Google Scholar]
  20. Lew, M. A., Beckett, K. M. & Levin, M. S. ( 1977; ). Antifungal activity of four tetracycline analogues in vitro: potentiation by amphotericin B. J Infect Dis 136, 263–270.[CrossRef]
    [Google Scholar]
  21. Lewis, R. E., Kontoyiannis, D. P., Darouiche, R. O., Raad, I. I. & Prince, R. A. ( 2002; ). Antifungal activity of amphotericin B, fluconazole, and voriconazole in an in vitro model of Candida catheter-related bloodstream infection. Antimicrob Agents Chemother 46, 3499–3505.[CrossRef]
    [Google Scholar]
  22. Lou, P., Kazdan, J., Bannatyne, R. M. & Cheung, R. ( 1977; ). Successful treatment of Candida albicans endophthalmitis with a synergistic combination of amphotericin B and rifampin. Am J Ophthalmol 83, 12–15.[CrossRef]
    [Google Scholar]
  23. Mah, T. F. & O’Toole, G. A. ( 2001; ). Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 9, 34–39.[CrossRef]
    [Google Scholar]
  24. Marrie, T. J. & Costerton, J. W. ( 1984; ). Scanning and transmission electron microscopy of in situ bacterial colonization of intraatrial catheter. J Clin Microbiol 19, 687–693.
    [Google Scholar]
  25. Medoff, G., Kobayashi, G. S., Kwan, C. N., Schlessinger, D. & Venkov, P. ( 1972; ). Potentiation of rifampicin and 5-fluorocytosine as antifungal antibiotics by amphotericin B. Proc Natl Acad Sci U S A 69, 196–199.[CrossRef]
    [Google Scholar]
  26. Pfaller, M. A., Jones, R. N., Doern, G. V., Sader, H. S., Messer, S. A., Houston, A., Coffman, S. & Hollis, R. J., the SENTRY Participant Group ( 2000; ). Bloodstream infections due to Candida Species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997–1998. Antimicrob Agents Chemother 44, 747–751.[CrossRef]
    [Google Scholar]
  27. Ramage, G., Vande Walle, K., Wickes, B. L. & Lopez-Ribot, J. L. ( 2001; ). Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemother 45, 2475–2479.[CrossRef]
    [Google Scholar]
  28. Samaranayake, Y. H., Ye, J., Yay, J. Y. & Cheung, B. P. ( 2005; ). In vitro method to study antifungal perfusion in Candida biofilms. J Clin Microbiol 43, 818–825.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.46952-0
Loading
/content/journal/jmm/10.1099/jmm.0.46952-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error